NDC 71384-511

Moxifloxacin PF

Moxifloxacin Pf

Moxifloxacin PF is a Ophthalmic Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Imprimis Njof, Llc. The primary component is Moxifloxacin Hydrochloride Monohydrate.

• Product ID: 71384-511_638f29bd-4f5a-d09a-e053-2a91aa0a017b
• NDC: 71384-511
• Product Type: Human Prescription Drug
• Proprietary Name: Moxifloxacin PF
• Generic Name: Moxifloxacin Pf
• Dosage Form: Injection, Solution
• Route of Administration: OPHTHALMIC
• Marketing Start Date: 2018-01-05
• Marketing Category: UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
• Labeler Name: Imprimis NJOF, LLC
• Substance Name: MOXIFLOXACIN HYDROCHLORIDE MONOHYDRATE
• Active Ingredient Strength: 5 mg/mL
• Pharm Classes: Quinolone Antimicrobial [EPC],Quinolones [CS]
• NDC Exclude Flag: N
• Listing Certified Through: 2019-12-31

Packaging

NDC 71384-511-01

20 VIAL, SINGLE-DOSE in 1 BOX (71384-511-01) > 1 mL in 1 VIAL, SINGLE-DOSE

• Marketing Start Date: 2018-01-05
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 71384-511-01 [71384051101]

Moxifloxacin PF INJECTION, SOLUTION

• Marketing Category: unapproved drug other
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2018-01-05
• Inactivation Date: 2020-01-31
• Reactivation Date: 2020-02-10

Drug Details

Active Ingredients

Ingredient	Strength
MOXIFLOXACIN HYDROCHLORIDE MONOHYDRATE	5 mg/mL

OpenFDA Data

• SPL SET ID: 62fde226-6140-2364-e053-2a91aa0a68bb
• Manufacturer:
  • Imprimis NJOF, LLC
• UNII:
  • B8956S8609

Pharmacological Class

• Quinolone Antimicrobial [EPC]
• Quinolones [CS]

NDC Crossover Matching brand name "Moxifloxacin PF" or generic name "Moxifloxacin Pf"

NDC	Brand Name	Generic Name
70261-511	Moxifloxacin PF	Moxifloxacin PF
71384-509	Moxifloxacin PF	Moxifloxacin PF
71384-511	Moxifloxacin PF	Moxifloxacin PF